Shelter Pharma Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Mar '26 Mar 31, 2026	Mar '25 Mar 31, 2025	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Cash & Equivalents	10.79	34.2	50.4	4.29	1
Cash & Short-Term Investments	10.79	34.2	50.4	4.29	1
Cash Growth	-68.45%	-32.14%	1076.13%	328.07%	-72.98%
Accounts Receivable	118.07	94.75	88.5	81.95	16.06
Other Receivables	-	-	-	-	0.84
Receivables	118.07	94.75	88.5	81.95	16.89
Inventory	244.39	128.95	99.29	79.65	56.74
Prepaid Expenses	-	-	0	0.01	0.01
Other Current Assets	177.24	74.89	59	21.27	23.68
Total Current Assets	550.49	332.79	297.19	187.16	98.32
Property, Plant & Equipment	66.83	59.51	35.71	18.45	20.05
Long-Term Investments	6.76	0.01	0.01	0.01	0.01
Other Intangible Assets	4.59	0.1	0.09	-	-
Long-Term Deferred Tax Assets	0.01	0.32	0.36	-	-
Other Long-Term Assets	213.66	90.63	45.81	8.87	10.02
Total Assets	842.33	483.36	379.15	214.48	128.39
Accounts Payable	12.54	12.51	7.14	4.68	3.23
Accrued Expenses	-	1.75	1.25	0.73	0.05
Short-Term Debt	2.67	1.13	0.04	13.04	0.38
Current Portion of Long-Term Debt	-	-	-	-	0.29
Current Income Taxes Payable	-	30.02	5.66	17.79	6.5
Current Unearned Revenue	-	-	-	25	-
Other Current Liabilities	54.8	0.88	0.66	1.24	26.63
Total Current Liabilities	70	46.29	14.75	62.48	37.07
Long-Term Debt	5.35	9.32	5.73	4.8	0.65
Pension & Post-Retirement Benefits	0.67	0.55	0.51	0.49	0.38
Long-Term Deferred Tax Liabilities	-	-	-	1.23	1.01
Other Long-Term Liabilities	-	-0	-0	-0	-0
Total Liabilities	76.01	56.15	20.99	69	39.11
Common Stock	166.12	115.6	115.6	77.44	4.84
Additional Paid-In Capital	-	122.11	122.11	39.96	39.96
Retained Earnings	-	180.08	111.03	18.67	35.07
Comprehensive Income & Other	600.2	9.42	9.42	9.42	9.42
Shareholders' Equity	766.32	427.21	358.16	145.49	89.29
Total Liabilities & Equity	842.33	483.36	379.15	214.48	128.39
Total Debt	8.01	10.44	5.77	17.84	1.31
Net Cash (Debt)	2.78	23.76	44.62	-13.56	-0.31
Net Cash Growth	-88.30%	-46.76%	-	-	-
Net Cash Per Share	0.16	2.06	3.86	-1.75	-0.04
Filing Date Shares Outstanding	15.91	11.56	11.56	11.56	7.74
Total Common Shares Outstanding	15.91	11.56	11.56	7.74	7.74
Working Capital	480.49	286.5	282.44	124.68	61.25
Book Value Per Share	48.17	36.96	30.98	18.79	11.53
Tangible Book Value	761.73	427.11	358.07	145.49	89.29
Tangible Book Value Per Share	47.88	36.95	30.98	18.79	11.53
Buildings	-	-	40.19	30.69	25.14
Machinery	-	-	10.58	6.56	6.52
Construction In Progress	-	-	6.18	-	5.55